Literature DB >> 32318109

Corrigendum to "Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation".

D Brocco1, P Lanuti2,3, P Simeone2,3, G Bologna2,3, D Pieragostino3,4, M C Cufaro3,4, V Graziano5,6, M Peri1, P Di Marino1, M De Tursi6, A Grassadonia6, I G Rapposelli7, L Pierdomenico2,3, E Ercolino2,3, F Ciccocioppo2,3, P Del Boccio3,8, M Marchisio2,3, C Natoli6, S Miscia2,3, N Tinari6.   

Abstract

[This corrects the article DOI: 10.1155/2019/5879616.].
Copyright © 2020 D. Brocco et al.

Entities:  

Year:  2020        PMID： 32318109      PMCID： PMC7150712          DOI： 10.1155/2020/8947367

Source DB:  PubMed          Journal:  J Oncol        ISSN： 1687-8450            Impact factor:   4.375


In the article titled “Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation” [1], the author Piero del Boccio was affiliated to Department of Medical, Oral and Biotechnological Sciences, University “G. D'Annunzio” of Chieti-Pescara, Analytical Biochemistry and Proteomics Laboratory, Chieti, Italy, which is incorrect. The corrected list of affiliations is shown above.
  1 in total

1.  Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation.

Authors:  D Brocco; P Lanuti; P Simeone; G Bologna; D Pieragostino; M C Cufaro; V Graziano; M Peri; P Di Marino; M De Tursi; A Grassadonia; I G Rapposelli; L Pierdomenico; E Ercolino; F Ciccocioppo; P Del Boccio; M Marchisio; C Natoli; S Miscia; N Tinari
Journal:  J Oncol       Date:  2019-11-18       Impact factor: 4.375
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.